The Hospital Acquired Infections (HAIs) Therapeutic Market is gaining renewed attention as hospitals worldwide intensify efforts to combat infection risks and improve patient safety standards. Valued at USD 13,875 million in 2024, the market is expected to expand at a CAGR of 3.70% between 2025 and 2032, driven by growing awareness of healthcare-associated infections and increased dem... https://analystviewmarketinsights.com/reports/report-highlight-hospital-acquired-infections-therapeutic-market